Thu, March 17, 2022
Wed, March 16, 2022
Tue, March 15, 2022

Andrew Fein Maintained (APRE) at Hold with Decreased Target to $40 on, Mar 16th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-40-on-mar-16th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Andrew Fein of HC Wainwright & Co., Maintained "Aprea Therapeutics, Inc." (APRE) at Hold with Decreased Target from $80 to $40 on, Mar 16th, 2022.

Andrew, nor any peers, have made any analyst calls on APRE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30